Arcutis Biotherapeutics, Inc. (ARQT) - Stock Prices, Stock Peers & Analysis

Home
ARQT

Company Name	Arcutis Biotherapeutics, Inc.
Symbol	ARQT
Currency	USD
Price	14.3
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,673,743,500
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	3.07 - 15.79
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Todd Franklin Watanabe M.A.
Website	https://www.arcutis.com

An error occurred while fetching data.

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam